Roberto Ruiz
Internal Medicine · Phoenix, AZNPI 1770578148
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Merck at 42.2% of the total. Reporting peaked in 2019 at $23,041 and has fallen 99.9% since, to $34 in 2023. Among internal medicine clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 281 payments — averaging $90.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$11K
- Kowa Pharmaceuticals America, Inc.$8K
- Sanofi-aventis U.S. LLC$3K
- AstraZeneca$652
- AbbVie$629
- Novo Nordisk$343
- plus $2K from 24 others
What the payments were for
- Consulting fees$2,3729%
- Speaking & faculty fees$12,86051%
- Travel & lodging$4,39317%
- Food & beverage$5,74323%
- Education$550%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 28 | $10,738 |
| Kowa Pharmaceuticals America, Inc. | 60 | $8,294 |
| Sanofi-aventis U.S. LLC | 33 | $2,791 |
| AstraZeneca | 22 | $652 |
| AbbVie | 28 | $629 |
| Novo Nordisk | 27 | $343 |
| Abbott | 9 | $326 |
| Lilly USA, LLC | 11 | $271 |
| Boehringer Ingelheim | 14 | $251 |
| Genentech USA, Inc. | 1 | $149 |
| Amarin Pharma, Inc. | 7 | $125 |
| Biohaven Pharmaceuticals, Inc. | 1 | $118 |
| Medtronic(2 entities) | 5 | $113 |
| Johnson & Johnson | 7 | $110 |
| Corcept Therapeutics | 3 | $75 |
| Esperion Therapeutics, Inc. | 3 | $72 |
| BD | 1 | $61 |
| Avion Pharmaceuticals | 2 | $34 |
| Valeritas, Inc. | 2 | $34 |
| Vivus LLC | 3 | $31 |
| Amgen | 2 | $30 |
| Janssen Scientific Affairs, LLC | 1 | $30 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Boston Scientific | 2 | $26 |
| Antares Pharma, Inc. | 2 | $25 |
| Shire North American Group Inc | 1 | $18 |
| Pfizer | 1 | $15 |
| Companion Medical, Inc. | 1 | $13 |
| Stryker | 1 | $12 |
| Aytu Biopharma, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STEGLATRO$10,560
- SOLIQUA 100/33$2,372
- Livalo$958
- Alecensa$149
- TECENTRIQ$149
- BOTOX$138
- Quadra Assura CRT Defibrillator$119
- NURTEC ODT$118
- XIGDUO$114
- Ozempic$110
- RYBELSUS$110
- Tresiba$110
- FARXIGA$101
How this compares
$25,423 in reported general payments places this provider in the 95th percentile of 2,212 internal medicine providers in Arizona.
Other internal medicine in Phoenix
- Frank LovecchioPhoenix$911K
- Nasser HajaigPhoenix$687K
- Kelly KrohnPhoenix$262K
- Paul StanderPhoenix$222K
- Howard GrossmanPhoenix$131K
- Nafis Shamsid-DeenPhoenix$115K
- Shishir MurarkaPhoenix$79K
- Mark WongPhoenix$71K
- Geoffrey OrmePhoenix$27K
- Louise TaberPhoenix$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.